Related Experiment Video
Updated: Jul 6, 2026

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala
Published on: June 29, 2022
[The neurochemical mechanisms of temporal lobe epilepsy: an update]
Monika Leśkiewicz1, Władysław Lasoń
1Instytut Farmakologii Polskiej Akademii Nauk w Krakowie, Zaklad Neuroendokrynologii.
Background:
Last decade witnessed a remarkable progress in understanding the molecular background of temporal lobe epilepsy. That success was due not only to undisputable achievements in the development of electrochemical and biological techniques, but also to the well-defined neuropathological features of partial epilepsy and the availability of appropriate animal models.
The Aim:
The aim of the present paper was to review recent reports concerning those issues. Special emphasis was put on glutamatergic and GABAergic systems, but the putative role of some neuropeptides, ion channels and intracellular signaling pathways in the pathomechanism of temporal epilepsy was also discussed.
Results:
The most intriguing and still unsolved problem with studying the basic mechanism of partial epilepsy is a mutual relationship between hippocampal damage and epileptogenesis, in particular the interaction of glia and neuronal factors in this long-term dynamic process.
Conclusions:
It is pointed out that better understanding of these molecular processes may have clinical implications in the future as regards preventing partial seizures, an accurate diagnosis and obtaining safer and more efficient antiepileptic drugs.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Long-term Potentiation
Long-term Potentiation
Hebbian LTP
LTP can occur when presynaptic neurons...
Long-term Depression
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

